Most Popular
-
1
10-man S. Korea lose to Indonesia to miss out on Paris Olympic football qualification
-
2
Hybe-Ador feud should have limited effect on Hybe's overall performance: analysts
-
3
Second Gimpo civil servant found dead, after apologizing for not finishing work
-
4
DP leader says he will meet Yoon without conditions
-
5
First-ever meeting of president, opposition chief set to finally happen
-
6
NewJeans' singles, Japanese debut to proceed as planned, despite Hybe-Ador feud
-
7
Blinken calls on China to press N. Korea to end its 'dangerous' behavior
-
8
Experts raise concerns about Japan putting pressure on Naver over Line
-
9
Samsung mobile chief, Google device head meet in Seoul
-
10
Ship linked to NK arms shipments to Russia is moored in China: State Dept.
[DISCLOSURE] KD Pharm (011040) announced on July 27 that it will repurchase 150,000 of its own shares, worth 2.88 billion won (US$2.53 million), to stabilize its stock price and increase value for stockholders.
The repurchase will be managed by Meritz Securities (008560).
The repurchase will be managed by Meritz Securities (008560).
